| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA896: Bulevirtide for treating chronic hepatitis D |
|
Medicine details |
|
| Medicine name | bulevirtide (Hepcludex®) |
| Formulation | powder for solution for injection |
| Reference number | 4426 |
| Indication | Treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease |
| Company | MYR Pharma |
| BNF chapter | Infections |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 14/10/2020 |
| NICE guidance | |